Publication rate of scientific papers presented at the largest event on breast cancer research in Latin America

FGFR as a tumour agnostic indicator and its importance in the diagnosis and treatment of multiple solid tumour types

Chemotherapy in colorectal cancer

ASCO 2021: Precision and molecular reporting for prostate cancer

Neo-AEGIS: Preliminary results of phase III RCT of CROSS versus perioperative chemotherapy

COSMIC-311: Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer

Childhood cancer: Early cancer detection through screening

Costa Rica´s Hepatitis B campaign

Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed MM

The clinical value of maintenance in multiple myeloma

Once weekly selinexor, carfilzomib, and dexamethasone (XKD) in carfilzomib non-refractory multiple myeloma patients

Isatuximab, carfilzomib, lenalidomide and dexamethasone for high risk MM